Osterweis Capital Management Inc. increased its stake in Danaher Co. (NYSE:DHR) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 340,881 shares of the conglomerate’s stock after purchasing an additional 1,531 shares during the quarter. Danaher makes up approximately 2.2% of Osterweis Capital Management Inc.’s investment portfolio, making the stock its 16th biggest position. Osterweis Capital Management Inc.’s holdings in Danaher were worth $31,640,000 as of its most recent filing with the SEC.
Other institutional investors also recently made changes to their positions in the company. MANA Advisors LLC purchased a new stake in Danaher in the 4th quarter worth $833,000. Bank of Nova Scotia Trust Co. grew its position in shares of Danaher by 58.4% during the fourth quarter. Bank of Nova Scotia Trust Co. now owns 53,097 shares of the conglomerate’s stock valued at $4,929,000 after purchasing an additional 19,569 shares in the last quarter. Renaissance Technologies LLC grew its position in shares of Danaher by 1,094.1% during the fourth quarter. Renaissance Technologies LLC now owns 1,149,900 shares of the conglomerate’s stock valued at $106,734,000 after purchasing an additional 1,053,600 shares in the last quarter. Scotia Capital Inc. grew its position in shares of Danaher by 42.7% during the fourth quarter. Scotia Capital Inc. now owns 44,278 shares of the conglomerate’s stock valued at $4,110,000 after purchasing an additional 13,245 shares in the last quarter. Finally, Signaturefd LLC grew its position in shares of Danaher by 29.3% during the fourth quarter. Signaturefd LLC now owns 3,304 shares of the conglomerate’s stock valued at $307,000 after purchasing an additional 749 shares in the last quarter. 77.83% of the stock is currently owned by institutional investors.
Danaher Co. (NYSE DHR) traded down $0.62 during midday trading on Wednesday, reaching $102.18. 1,510,000 shares of the company were exchanged, compared to its average volume of 2,870,000. The firm has a market capitalization of $71,280.00, a P/E ratio of 29.19, a PEG ratio of 2.17 and a beta of 1.04. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The business had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the prior year, the firm posted $1.05 earnings per share. The company’s revenue was up 10.9% compared to the same quarter last year. equities analysts predict that Danaher Co. will post 4.37 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio is currently 16.00%.
In other news, insider Rainer Blair sold 3,981 shares of the stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $100.05, for a total value of $398,299.05. Following the completion of the sale, the insider now owns 49,751 shares of the company’s stock, valued at approximately $4,977,587.55. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Daniel L. Comas sold 62,989 shares of the stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the completion of the sale, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at approximately $23,226,997.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 313,260 shares of company stock valued at $31,657,786. 12.20% of the stock is owned by corporate insiders.
Several research firms recently commented on DHR. Credit Suisse Group reiterated an “outperform” rating on shares of Danaher in a research report on Friday, March 9th. Morgan Stanley raised their price objective on shares of Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 31st. Evercore ISI began coverage on shares of Danaher in a research note on Wednesday, January 3rd. They issued an “outperform” rating for the company. Argus raised their price objective on shares of Danaher from $100.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Finally, Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $101.40.
WARNING: “Osterweis Capital Management Inc. Has $31.64 Million Stake in Danaher Co. (NYSE:DHR)” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/14/danaher-co-dhr-holdings-boosted-by-osterweis-capital-management-inc.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.